nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Zidovudine—TERT—skin cancer	0.0246	1	CrCbGaD
Telbivudine—Tenderness—Fluorouracil—skin cancer	0.00537	0.0055	CcSEcCtD
Telbivudine—Influenza—Imiquimod—skin cancer	0.00532	0.00546	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00523	0.00537	CcSEcCtD
Telbivudine—Musculoskeletal pain—Temozolomide—skin cancer	0.00515	0.00528	CcSEcCtD
Telbivudine—Dyspepsia—Vismodegib—skin cancer	0.00506	0.00518	CcSEcCtD
Telbivudine—Pharyngolaryngeal pain—Docetaxel—skin cancer	0.00501	0.00513	CcSEcCtD
Telbivudine—Laryngeal pain—Docetaxel—skin cancer	0.00496	0.00508	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00496	0.00508	CcSEcCtD
Telbivudine—Fatigue—Vismodegib—skin cancer	0.00495	0.00508	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Imiquimod—skin cancer	0.00495	0.00507	CcSEcCtD
Telbivudine—Influenza like illness—Temozolomide—skin cancer	0.00494	0.00506	CcSEcCtD
Telbivudine—Pain—Vismodegib—skin cancer	0.00491	0.00504	CcSEcCtD
Telbivudine—Connective tissue disorder—Vemurafenib—skin cancer	0.00491	0.00503	CcSEcCtD
Telbivudine—Sepsis—Dactinomycin—skin cancer	0.00488	0.005	CcSEcCtD
Telbivudine—Gastrointestinal pain—Vismodegib—skin cancer	0.0047	0.00482	CcSEcCtD
Telbivudine—Neuropathy peripheral—Imiquimod—skin cancer	0.00465	0.00477	CcSEcCtD
Telbivudine—Abdominal pain—Vismodegib—skin cancer	0.00454	0.00466	CcSEcCtD
Telbivudine—Mediastinal disorder—Vemurafenib—skin cancer	0.0045	0.00462	CcSEcCtD
Telbivudine—Hepatobiliary disease—Imiquimod—skin cancer	0.00449	0.0046	CcSEcCtD
Telbivudine—Malnutrition—Vemurafenib—skin cancer	0.00435	0.00446	CcSEcCtD
Telbivudine—Dysgeusia—Vemurafenib—skin cancer	0.00426	0.00437	CcSEcCtD
Telbivudine—Pharyngitis—Imiquimod—skin cancer	0.00423	0.00433	CcSEcCtD
Telbivudine—Back pain—Vemurafenib—skin cancer	0.00421	0.00431	CcSEcCtD
Telbivudine—Connective tissue disorder—Imiquimod—skin cancer	0.00419	0.00429	CcSEcCtD
Telbivudine—Rhinorrhoea—Docetaxel—skin cancer	0.00417	0.00428	CcSEcCtD
Telbivudine—Asthenia—Vismodegib—skin cancer	0.00412	0.00423	CcSEcCtD
Telbivudine—Sepsis—Fluorouracil—skin cancer	0.00406	0.00417	CcSEcCtD
Telbivudine—Pruritus—Vismodegib—skin cancer	0.00406	0.00417	CcSEcCtD
Telbivudine—Diarrhoea—Vismodegib—skin cancer	0.00393	0.00403	CcSEcCtD
Telbivudine—Mediastinal disorder—Imiquimod—skin cancer	0.00384	0.00394	CcSEcCtD
Telbivudine—Chest discomfort—Docetaxel—skin cancer	0.00382	0.00392	CcSEcCtD
Telbivudine—Cough—Vemurafenib—skin cancer	0.00379	0.00389	CcSEcCtD
Telbivudine—Malnutrition—Imiquimod—skin cancer	0.00371	0.0038	CcSEcCtD
Telbivudine—Arthralgia—Vemurafenib—skin cancer	0.0037	0.0038	CcSEcCtD
Telbivudine—Myalgia—Vemurafenib—skin cancer	0.0037	0.0038	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00368	0.00377	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.00367	0.00377	CcSEcCtD
Telbivudine—Vomiting—Vismodegib—skin cancer	0.00365	0.00374	CcSEcCtD
Telbivudine—Rash—Vismodegib—skin cancer	0.00362	0.00371	CcSEcCtD
Telbivudine—Dermatitis—Vismodegib—skin cancer	0.00362	0.00371	CcSEcCtD
Telbivudine—Back pain—Imiquimod—skin cancer	0.00359	0.00368	CcSEcCtD
Telbivudine—Nervous system disorder—Vemurafenib—skin cancer	0.00348	0.00357	CcSEcCtD
Telbivudine—Skin disorder—Vemurafenib—skin cancer	0.00345	0.00353	CcSEcCtD
Telbivudine—Ill-defined disorder—Imiquimod—skin cancer	0.00344	0.00353	CcSEcCtD
Telbivudine—Nausea—Vismodegib—skin cancer	0.00341	0.0035	CcSEcCtD
Telbivudine—Malaise—Imiquimod—skin cancer	0.00334	0.00343	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00332	0.00341	CcSEcCtD
Telbivudine—Neutropenia—Dactinomycin—skin cancer	0.0033	0.00338	CcSEcCtD
Telbivudine—Influenza like illness—Docetaxel—skin cancer	0.00328	0.00337	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Temozolomide—skin cancer	0.00325	0.00334	CcSEcCtD
Telbivudine—Muscular weakness—Temozolomide—skin cancer	0.00325	0.00334	CcSEcCtD
Telbivudine—Cough—Imiquimod—skin cancer	0.00324	0.00332	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00323	0.00331	CcSEcCtD
Telbivudine—Abdominal distension—Temozolomide—skin cancer	0.00321	0.00329	CcSEcCtD
Telbivudine—Arthralgia—Imiquimod—skin cancer	0.00316	0.00324	CcSEcCtD
Telbivudine—Myalgia—Imiquimod—skin cancer	0.00316	0.00324	CcSEcCtD
Telbivudine—Chest pain—Imiquimod—skin cancer	0.00316	0.00324	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00314	0.00321	CcSEcCtD
Telbivudine—Discomfort—Imiquimod—skin cancer	0.00312	0.0032	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00306	0.00314	CcSEcCtD
Telbivudine—Fatigue—Vemurafenib—skin cancer	0.00306	0.00314	CcSEcCtD
Telbivudine—Nasopharyngitis—Fluorouracil—skin cancer	0.00304	0.00312	CcSEcCtD
Telbivudine—Hypoaesthesia—Bleomycin—skin cancer	0.00301	0.00309	CcSEcCtD
Telbivudine—Muscular weakness—Fluorouracil—skin cancer	0.003	0.00307	CcSEcCtD
Telbivudine—Neutropenia—Temozolomide—skin cancer	0.00298	0.00306	CcSEcCtD
Telbivudine—Nervous system disorder—Imiquimod—skin cancer	0.00297	0.00304	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Temozolomide—skin cancer	0.00296	0.00304	CcSEcCtD
Telbivudine—Skin disorder—Imiquimod—skin cancer	0.00294	0.00301	CcSEcCtD
Telbivudine—Sepsis—Docetaxel—skin cancer	0.00293	0.00301	CcSEcCtD
Telbivudine—Hepatitis—Dactinomycin—skin cancer	0.00282	0.00289	CcSEcCtD
Telbivudine—Body temperature increased—Vemurafenib—skin cancer	0.00281	0.00288	CcSEcCtD
Telbivudine—Pharyngitis—Dactinomycin—skin cancer	0.0028	0.00287	CcSEcCtD
Telbivudine—Neuropathy peripheral—Temozolomide—skin cancer	0.00279	0.00286	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00276	0.00283	CcSEcCtD
Telbivudine—Insomnia—Imiquimod—skin cancer	0.00274	0.00281	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00273	0.0028	CcSEcCtD
Telbivudine—Paraesthesia—Imiquimod—skin cancer	0.00272	0.00279	CcSEcCtD
Telbivudine—Hepatobiliary disease—Temozolomide—skin cancer	0.00269	0.00276	CcSEcCtD
Telbivudine—Dyspepsia—Imiquimod—skin cancer	0.00266	0.00273	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00261	0.00268	CcSEcCtD
Telbivudine—Fatigue—Imiquimod—skin cancer	0.00261	0.00268	CcSEcCtD
Telbivudine—Pain—Imiquimod—skin cancer	0.00259	0.00265	CcSEcCtD
Telbivudine—Renal impairment—Docetaxel—skin cancer	0.00258	0.00264	CcSEcCtD
Telbivudine—Neuropathy peripheral—Fluorouracil—skin cancer	0.00257	0.00263	CcSEcCtD
Telbivudine—Hepatitis—Temozolomide—skin cancer	0.00255	0.00262	CcSEcCtD
Telbivudine—Asthenia—Vemurafenib—skin cancer	0.00255	0.00261	CcSEcCtD
Telbivudine—Hypoaesthesia—Temozolomide—skin cancer	0.00254	0.0026	CcSEcCtD
Telbivudine—Pharyngitis—Temozolomide—skin cancer	0.00253	0.0026	CcSEcCtD
Telbivudine—Pruritus—Vemurafenib—skin cancer	0.00251	0.00257	CcSEcCtD
Telbivudine—Connective tissue disorder—Temozolomide—skin cancer	0.00251	0.00257	CcSEcCtD
Telbivudine—Feeling abnormal—Imiquimod—skin cancer	0.00249	0.00256	CcSEcCtD
Telbivudine—Gastrointestinal pain—Imiquimod—skin cancer	0.00247	0.00254	CcSEcCtD
Telbivudine—Pain in extremity—Docetaxel—skin cancer	0.00245	0.00252	CcSEcCtD
Telbivudine—Ill-defined disorder—Bleomycin—skin cancer	0.00244	0.00251	CcSEcCtD
Telbivudine—Diarrhoea—Vemurafenib—skin cancer	0.00243	0.00249	CcSEcCtD
Telbivudine—Migraine—Docetaxel—skin cancer	0.00242	0.00248	CcSEcCtD
Telbivudine—Abdominal pain—Imiquimod—skin cancer	0.00239	0.00245	CcSEcCtD
Telbivudine—Body temperature increased—Imiquimod—skin cancer	0.00239	0.00245	CcSEcCtD
Telbivudine—Malaise—Bleomycin—skin cancer	0.00238	0.00244	CcSEcCtD
Telbivudine—Dizziness—Vemurafenib—skin cancer	0.00235	0.00241	CcSEcCtD
Telbivudine—Hypoaesthesia—Fluorouracil—skin cancer	0.00234	0.0024	CcSEcCtD
Telbivudine—Pharyngitis—Fluorouracil—skin cancer	0.00233	0.00239	CcSEcCtD
Telbivudine—Mediastinal disorder—Temozolomide—skin cancer	0.0023	0.00236	CcSEcCtD
Telbivudine—Cough—Bleomycin—skin cancer	0.0023	0.00236	CcSEcCtD
Telbivudine—Ill-defined disorder—Dactinomycin—skin cancer	0.00228	0.00234	CcSEcCtD
Telbivudine—Vomiting—Vemurafenib—skin cancer	0.00226	0.00231	CcSEcCtD
Telbivudine—Chest pain—Bleomycin—skin cancer	0.00224	0.0023	CcSEcCtD
Telbivudine—Myalgia—Bleomycin—skin cancer	0.00224	0.0023	CcSEcCtD
Telbivudine—Abdominal pain upper—Docetaxel—skin cancer	0.00224	0.0023	CcSEcCtD
Telbivudine—Rash—Vemurafenib—skin cancer	0.00224	0.00229	CcSEcCtD
Telbivudine—Dermatitis—Vemurafenib—skin cancer	0.00224	0.00229	CcSEcCtD
Telbivudine—Headache—Vemurafenib—skin cancer	0.00222	0.00228	CcSEcCtD
Telbivudine—Malnutrition—Temozolomide—skin cancer	0.00222	0.00228	CcSEcCtD
Telbivudine—Discomfort—Bleomycin—skin cancer	0.00222	0.00227	CcSEcCtD
Telbivudine—Malaise—Dactinomycin—skin cancer	0.00222	0.00227	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00221	0.00227	CcSEcCtD
Telbivudine—Cramp muscle—Docetaxel—skin cancer	0.00221	0.00227	CcSEcCtD
Telbivudine—Nasopharyngitis—Docetaxel—skin cancer	0.00219	0.00225	CcSEcCtD
Telbivudine—Dysgeusia—Temozolomide—skin cancer	0.00218	0.00223	CcSEcCtD
Telbivudine—Asthenia—Imiquimod—skin cancer	0.00217	0.00223	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00216	0.00222	CcSEcCtD
Telbivudine—Back pain—Temozolomide—skin cancer	0.00215	0.0022	CcSEcCtD
Telbivudine—Pruritus—Imiquimod—skin cancer	0.00214	0.0022	CcSEcCtD
Telbivudine—Nausea—Vemurafenib—skin cancer	0.00211	0.00216	CcSEcCtD
Telbivudine—Thrombocytopenia—Bleomycin—skin cancer	0.00211	0.00216	CcSEcCtD
Telbivudine—Myalgia—Dactinomycin—skin cancer	0.00209	0.00214	CcSEcCtD
Telbivudine—Diarrhoea—Imiquimod—skin cancer	0.00207	0.00212	CcSEcCtD
Telbivudine—Discomfort—Dactinomycin—skin cancer	0.00207	0.00212	CcSEcCtD
Telbivudine—Ill-defined disorder—Temozolomide—skin cancer	0.00206	0.00211	CcSEcCtD
Telbivudine—Malaise—Temozolomide—skin cancer	0.002	0.00205	CcSEcCtD
Telbivudine—Dizziness—Imiquimod—skin cancer	0.002	0.00205	CcSEcCtD
Telbivudine—Neutropenia—Docetaxel—skin cancer	0.00198	0.00203	CcSEcCtD
Telbivudine—Thrombocytopenia—Dactinomycin—skin cancer	0.00196	0.00201	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00196	0.00201	CcSEcCtD
Telbivudine—Cough—Temozolomide—skin cancer	0.00194	0.00199	CcSEcCtD
Telbivudine—Paraesthesia—Bleomycin—skin cancer	0.00193	0.00198	CcSEcCtD
Telbivudine—Vomiting—Imiquimod—skin cancer	0.00192	0.00197	CcSEcCtD
Telbivudine—Rash—Imiquimod—skin cancer	0.00191	0.00196	CcSEcCtD
Telbivudine—Dermatitis—Imiquimod—skin cancer	0.00191	0.00195	CcSEcCtD
Telbivudine—Headache—Imiquimod—skin cancer	0.0019	0.00194	CcSEcCtD
Telbivudine—Arthralgia—Temozolomide—skin cancer	0.00189	0.00194	CcSEcCtD
Telbivudine—Myalgia—Temozolomide—skin cancer	0.00189	0.00194	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00188	0.00193	CcSEcCtD
Telbivudine—Discomfort—Temozolomide—skin cancer	0.00187	0.00192	CcSEcCtD
Telbivudine—Renal failure—Docetaxel—skin cancer	0.00186	0.00191	CcSEcCtD
Telbivudine—Neuropathy peripheral—Docetaxel—skin cancer	0.00185	0.0019	CcSEcCtD
Telbivudine—Pain—Bleomycin—skin cancer	0.00184	0.00189	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00183	0.00187	CcSEcCtD
Telbivudine—Nausea—Imiquimod—skin cancer	0.0018	0.00184	CcSEcCtD
Telbivudine—Hepatobiliary disease—Docetaxel—skin cancer	0.00179	0.00183	CcSEcCtD
Telbivudine—Nervous system disorder—Temozolomide—skin cancer	0.00178	0.00182	CcSEcCtD
Telbivudine—Thrombocytopenia—Temozolomide—skin cancer	0.00178	0.00182	CcSEcCtD
Telbivudine—Feeling abnormal—Bleomycin—skin cancer	0.00177	0.00182	CcSEcCtD
Telbivudine—Skin disorder—Temozolomide—skin cancer	0.00176	0.00181	CcSEcCtD
Telbivudine—Myalgia—Fluorouracil—skin cancer	0.00174	0.00179	CcSEcCtD
Telbivudine—Chest pain—Fluorouracil—skin cancer	0.00174	0.00179	CcSEcCtD
Telbivudine—Fatigue—Dactinomycin—skin cancer	0.00173	0.00177	CcSEcCtD
Telbivudine—Discomfort—Fluorouracil—skin cancer	0.00172	0.00177	CcSEcCtD
Telbivudine—Pain—Dactinomycin—skin cancer	0.00171	0.00176	CcSEcCtD
Telbivudine—Body temperature increased—Bleomycin—skin cancer	0.0017	0.00174	CcSEcCtD
Telbivudine—Hepatitis—Docetaxel—skin cancer	0.0017	0.00174	CcSEcCtD
Telbivudine—Hypoaesthesia—Docetaxel—skin cancer	0.00169	0.00173	CcSEcCtD
Telbivudine—Pharyngitis—Docetaxel—skin cancer	0.00168	0.00173	CcSEcCtD
Telbivudine—Connective tissue disorder—Docetaxel—skin cancer	0.00167	0.00171	CcSEcCtD
Telbivudine—Feeling abnormal—Dactinomycin—skin cancer	0.00165	0.00169	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00165	0.00169	CcSEcCtD
Telbivudine—Insomnia—Temozolomide—skin cancer	0.00164	0.00168	CcSEcCtD
Telbivudine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00164	0.00168	CcSEcCtD
Telbivudine—Nervous system disorder—Fluorouracil—skin cancer	0.00164	0.00168	CcSEcCtD
Telbivudine—Thrombocytopenia—Fluorouracil—skin cancer	0.00164	0.00168	CcSEcCtD
Telbivudine—Paraesthesia—Temozolomide—skin cancer	0.00163	0.00167	CcSEcCtD
Telbivudine—Dyspepsia—Temozolomide—skin cancer	0.0016	0.00164	CcSEcCtD
Telbivudine—Abdominal pain—Dactinomycin—skin cancer	0.00159	0.00163	CcSEcCtD
Telbivudine—Body temperature increased—Dactinomycin—skin cancer	0.00159	0.00163	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00157	0.00161	CcSEcCtD
Telbivudine—Fatigue—Temozolomide—skin cancer	0.00156	0.0016	CcSEcCtD
Telbivudine—Pain—Temozolomide—skin cancer	0.00155	0.00159	CcSEcCtD
Telbivudine—Asthenia—Bleomycin—skin cancer	0.00154	0.00158	CcSEcCtD
Telbivudine—Mediastinal disorder—Docetaxel—skin cancer	0.00153	0.00157	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00152	0.00156	CcSEcCtD
Telbivudine—Pruritus—Bleomycin—skin cancer	0.00152	0.00156	CcSEcCtD
Telbivudine—Insomnia—Fluorouracil—skin cancer	0.00151	0.00155	CcSEcCtD
Telbivudine—Paraesthesia—Fluorouracil—skin cancer	0.0015	0.00154	CcSEcCtD
Telbivudine—Feeling abnormal—Temozolomide—skin cancer	0.00149	0.00153	CcSEcCtD
Telbivudine—Gastrointestinal pain—Temozolomide—skin cancer	0.00148	0.00152	CcSEcCtD
Telbivudine—Malnutrition—Docetaxel—skin cancer	0.00148	0.00152	CcSEcCtD
Telbivudine—Dyspepsia—Fluorouracil—skin cancer	0.00147	0.00151	CcSEcCtD
Telbivudine—Dysgeusia—Docetaxel—skin cancer	0.00145	0.00148	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00144	0.00148	CcSEcCtD
Telbivudine—Asthenia—Dactinomycin—skin cancer	0.00144	0.00147	CcSEcCtD
Telbivudine—Abdominal pain—Temozolomide—skin cancer	0.00143	0.00147	CcSEcCtD
Telbivudine—Body temperature increased—Temozolomide—skin cancer	0.00143	0.00147	CcSEcCtD
Telbivudine—Back pain—Docetaxel—skin cancer	0.00143	0.00147	CcSEcCtD
Telbivudine—Pain—Fluorouracil—skin cancer	0.00143	0.00147	CcSEcCtD
Telbivudine—Muscle spasms—Docetaxel—skin cancer	0.00142	0.00146	CcSEcCtD
Telbivudine—Feeling abnormal—Fluorouracil—skin cancer	0.00138	0.00141	CcSEcCtD
Telbivudine—Diarrhoea—Dactinomycin—skin cancer	0.00137	0.00141	CcSEcCtD
Telbivudine—Vomiting—Bleomycin—skin cancer	0.00137	0.0014	CcSEcCtD
Telbivudine—Rash—Bleomycin—skin cancer	0.00136	0.00139	CcSEcCtD
Telbivudine—Dermatitis—Bleomycin—skin cancer	0.00135	0.00139	CcSEcCtD
Telbivudine—Body temperature increased—Fluorouracil—skin cancer	0.00132	0.00135	CcSEcCtD
Telbivudine—Asthenia—Temozolomide—skin cancer	0.0013	0.00133	CcSEcCtD
Telbivudine—Cough—Docetaxel—skin cancer	0.00129	0.00132	CcSEcCtD
Telbivudine—Pruritus—Temozolomide—skin cancer	0.00128	0.00132	CcSEcCtD
Telbivudine—Nausea—Bleomycin—skin cancer	0.00128	0.00131	CcSEcCtD
Telbivudine—Vomiting—Dactinomycin—skin cancer	0.00127	0.00131	CcSEcCtD
Telbivudine—Rash—Dactinomycin—skin cancer	0.00126	0.0013	CcSEcCtD
Telbivudine—Arthralgia—Docetaxel—skin cancer	0.00126	0.00129	CcSEcCtD
Telbivudine—Chest pain—Docetaxel—skin cancer	0.00126	0.00129	CcSEcCtD
Telbivudine—Myalgia—Docetaxel—skin cancer	0.00126	0.00129	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00125	0.00128	CcSEcCtD
Telbivudine—Diarrhoea—Temozolomide—skin cancer	0.00124	0.00127	CcSEcCtD
Telbivudine—Dizziness—Temozolomide—skin cancer	0.0012	0.00123	CcSEcCtD
Telbivudine—Nausea—Dactinomycin—skin cancer	0.00119	0.00122	CcSEcCtD
Telbivudine—Nervous system disorder—Docetaxel—skin cancer	0.00118	0.00121	CcSEcCtD
Telbivudine—Pruritus—Fluorouracil—skin cancer	0.00118	0.00121	CcSEcCtD
Telbivudine—Thrombocytopenia—Docetaxel—skin cancer	0.00118	0.00121	CcSEcCtD
Telbivudine—Skin disorder—Docetaxel—skin cancer	0.00117	0.0012	CcSEcCtD
Telbivudine—Vomiting—Temozolomide—skin cancer	0.00115	0.00118	CcSEcCtD
Telbivudine—Rash—Temozolomide—skin cancer	0.00114	0.00117	CcSEcCtD
Telbivudine—Diarrhoea—Fluorouracil—skin cancer	0.00114	0.00117	CcSEcCtD
Telbivudine—Dermatitis—Temozolomide—skin cancer	0.00114	0.00117	CcSEcCtD
Telbivudine—Headache—Temozolomide—skin cancer	0.00114	0.00116	CcSEcCtD
Telbivudine—Dizziness—Fluorouracil—skin cancer	0.00111	0.00113	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.0011	0.00113	CcSEcCtD
Telbivudine—Insomnia—Docetaxel—skin cancer	0.00109	0.00112	CcSEcCtD
Telbivudine—Paraesthesia—Docetaxel—skin cancer	0.00108	0.00111	CcSEcCtD
Telbivudine—Nausea—Temozolomide—skin cancer	0.00108	0.0011	CcSEcCtD
Telbivudine—Vomiting—Fluorouracil—skin cancer	0.00106	0.00109	CcSEcCtD
Telbivudine—Dyspepsia—Docetaxel—skin cancer	0.00106	0.00109	CcSEcCtD
Telbivudine—Rash—Fluorouracil—skin cancer	0.00105	0.00108	CcSEcCtD
Telbivudine—Dermatitis—Fluorouracil—skin cancer	0.00105	0.00108	CcSEcCtD
Telbivudine—Headache—Fluorouracil—skin cancer	0.00105	0.00107	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00104	0.00107	CcSEcCtD
Telbivudine—Fatigue—Docetaxel—skin cancer	0.00104	0.00107	CcSEcCtD
Telbivudine—Pain—Docetaxel—skin cancer	0.00103	0.00106	CcSEcCtD
Telbivudine—Feeling abnormal—Docetaxel—skin cancer	0.000994	0.00102	CcSEcCtD
Telbivudine—Nausea—Fluorouracil—skin cancer	0.000993	0.00102	CcSEcCtD
Telbivudine—Gastrointestinal pain—Docetaxel—skin cancer	0.000986	0.00101	CcSEcCtD
Telbivudine—Abdominal pain—Docetaxel—skin cancer	0.000953	0.000978	CcSEcCtD
Telbivudine—Body temperature increased—Docetaxel—skin cancer	0.000953	0.000978	CcSEcCtD
Telbivudine—Asthenia—Docetaxel—skin cancer	0.000865	0.000887	CcSEcCtD
Telbivudine—Pruritus—Docetaxel—skin cancer	0.000853	0.000875	CcSEcCtD
Telbivudine—Diarrhoea—Docetaxel—skin cancer	0.000825	0.000846	CcSEcCtD
Telbivudine—Dizziness—Docetaxel—skin cancer	0.000798	0.000818	CcSEcCtD
Telbivudine—Vomiting—Docetaxel—skin cancer	0.000767	0.000786	CcSEcCtD
Telbivudine—Rash—Docetaxel—skin cancer	0.00076	0.00078	CcSEcCtD
Telbivudine—Dermatitis—Docetaxel—skin cancer	0.00076	0.000779	CcSEcCtD
Telbivudine—Headache—Docetaxel—skin cancer	0.000756	0.000775	CcSEcCtD
Telbivudine—Nausea—Docetaxel—skin cancer	0.000716	0.000734	CcSEcCtD
